Bladder-sparing strategies for transitional cell carcinoma.
Feneley
M R
MR
James Buchanan Brady Urological Institute, Department of Urology, Johns Hopkins University Medical Institutions, Baltimore, Maryland, USA.
Schoenberg
M
M
D002295:Carcinoma, Transitional Cell / Q000401:mortality / Q000556:secondary / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D015653:Cystectomy / Q000379:methods*; D006801:Humans; D019060:Minimally Invasive Surgical Procedures / Q000379:methods*; D018714:Radiotherapy, Adjuvant; D015996:Survival Rate; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000401:mortality / Q000601:surgery*